Nearly 40% of women with a notoriously difficult to treat, triple-negative breast cancer diagnosis had their cancer shrink or go away entirely with a new immunotherapy triple-drug treatment developed by researchers at Baltimore-based Johns Hopkins Medicine.

The "try-everything tactic" appears to bring meaningful improvements in some cancer patients, but the approach comes with caveats, according to a Feb. 14 article in Nature.

While other physician specialties have seen a decline in burnout, oncologists are reporting slightly higher rates of burnout.

Uterine cancer diagnosis and mortality rates both continue to increase, according to the latest data from the American Cancer Society. It is also the only cancer for which survival rates have continuously fallen over the last 40 years.

For many, recent headlines on cancer rates rising among younger adults have been jarring. But those working in oncology have had their eyes on worrisome trends for more than a decade.  

The investigation into a possible cancer cluster at Chapel Hill, N.C.-based UNC Health will continue after the air quality inspection came back clean.

Phoenix-based Banner Imaging is utilizing a new mammogram technique to improve early detection of abnormalities.

Nashville, Tenn.-based OneOncology and Myrtle Beach, S.C.-based Coastal Cancer Center purchased two radiation oncology centers from GenesisCare.

Rising rates of colon cancer in adults younger than 50 continue to puzzle medical experts. But recent research from Cleveland Clinic found changes in the tumor-associated bacteria of patients under 50 with a colon cancer diagnosis.

The National Comprehensive Cancer Network, a non-profit comprised of 33 leading cancer centers across the U.S., has published the first set of guidelines for oncologists about treating solid tumors in children.

New findings from researchers at Cleveland Clinic have revealed that bacteria in tumors from patients with young-onset colorectal cancer are compositionally distinct, which could help inform targeted approaches to screening and treatments. 

Most cancer centers and hospitals with strong cancer programs were rated in the "A" range by Moody, a global provider of credit ratings and risk assessment.

The first patient to receive purified CAR-T cells is home and doing well, Charleston, S.C.-based MUSC Hollings Cancer Center said.

Of all cancer cases in men in 2024, 48% are predicted to be prostate, lung and colon and rectum and 51% of all new cases in women are expected to be from breast, lung and colon and rectum cancers, researchers from the American Cancer Society found.

A "legendary" Houston oncologist has developed a novel cancer treatment that boasts a complete remission rate among patients of 50%, ABC7 reported Feb. 3.

Here are six cancer vaccines showing promise or in development since May 2023: 

Early trials of a vaccine that targets a specific gene found in tumors, known as KRAS, has proven to be effective in 84% of patients who had pancreatic or colorectal cancers recur after their initial treatment, according to researchers at Memorial Sloan Kettering Cancer Center in New York City who co-led the study.

Little Rock-based University of Arkansas for Medical Sciences reached its $30 million fundraising goal and is closer to becoming a national cancer institute.

New estimates suggest that global cancer cases will spike around 77% by 2050, according to a Feb. 1 United Nations report. 

The Rutgers Cancer Institute of New Jersey has promoted two leadership positions to better situate it for support of the new Jack and Sheryl Morris Cancer Center in New Brunswick, N.J., set to open in early 2025.